Efficacy of cyclosporin-A in refractory rheumatoid arthritis

Journal of the College of Physicians and Surgeons Pakistan

Volumn 14, Issue 3, 2004, Pages 139-141

  Farooqui, Abu Noem ^a   Ahmad, Syed Layeeq ^a   Mansuri, Farah Asad ^a  

^a ABBASI SHAHEED HOSPITAL   (Pakistan)

Author keywords

Articular index; Cyclosporin A; Methotrexate; Refractory disease; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; CYCLOSPORIN A; METHOTREXATE; CYCLOSPORIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; GRIP STRENGTH; HAND GRIP; HUMAN; JOINT FUNCTION; MAJOR CLINICAL STUDY; MALE; RHEUMATOID ARTHRITIS; SIDE EFFECT; SINGLE BLIND PROCEDURE; VISUAL ANALOG SCALE; PAIN ASSESSMENT;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CYCLOSPORINE; HUMANS; PAIN MEASUREMENT; SINGLE-BLIND METHOD;

EID: 3142708526     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Rheumatoid arthritis. In: Peter EL, (edi). Principles of internal medicine. Vol II. 14 th ed. New York: Mac Graw-Hill.
2. Haagsma CJ. Clinically important drugs interactions with disease-modifying anti-rheumatic drugs. Drugs Aging 1998; 13:281-9.
3. Carpenter N, Bertin P, Cabanac DM, Abdeddaim M, Vergnne P, Bonnet C, et al. Long-term cyclosporin continuation rates in rheumatoid arthritis patients. Revue du Rheumatism 1999; 66: 245-9.
4. Tugwell P, Pincus T, Yocum D, Stein M, Gluck O, Kraag G. Combination therapy with cyclosporin and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995; 333:137-41.
5. van den Borne BE, Landewe RB, Houkes I, Schild F, van der Heyden PC, Hazes JM, et al. No increased risk of malignancies and mortality in cyclosporin-A treated patients with rheumatoid arthritis. Arthritis Rheum 1998; 41: 1930-7.
6. Yocum D. The role of T-cells in rheumatoid arthritis and the use of immuno-modulating drugs. Drugs Today 1999; 35: 295-307.
7. Pincus T. Combination therapy for rheumatoid arthritis with methotrexate and cyclosporin. J Rheumatol 1998, 38: 254-9.
8. Proudman SM, Conaghan PG, Richardson C, Griffiths B, Green MJ, McGonagle D, et al. Treatment of poor prognosis early rheumatoid arthritis: a randomized study of treatment with methotrexate, cyclosporin-A and Intra articular cortioosteroids compared with sulfasalazine alone. Arthritis Rheum,2000; 43: 1809-19.
9. Drosos AA, Voulgaris PV, Katsaraki A, Zikou AK. Influence of cyclosporin-A on radiographic progression in early rheumatoid arthritis patients: a 42-months prospective study. Rheumatol Int 2000, 19:113-8.
10. Pharm B, Cranney A, Boers M, Verhoeven AC, Wells G, Tugwell P. Validity of area under the curve:analysis to summarize the effect in rheumatoid arthritis clinical trials. J Rheumatol 1999; 26: 712-6.
11. Paulus HE, Bulpitt KJ. DC-ART classification: review of relevant clinical studies. J Rheumatol 1994; 41:(21 suppl), 8-22.
12. Langford CA, Klippel JH, Balow JE, James SP, Sneller MC. Use of cytotoxic agents and cyclosporin in the treatment of autoimmune disease. Part I: rheumatologic and renal diseases. Ann Intern Med 1998; 128,1021-8.
13. Pasero G, Priolo F, Marubinni E, Fantini F, Ferracolli G, Magaro M, et al. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin-A. Arthritis Rheumat 1996; 49: 1006-14.
14. Marchesoni A, Fantini F, Battafaran N, Zeni S, Rui G, Padula A, et al. Pharmacokinetic effects of conversion to a new formulation of cyclosporin-A in rheumatoid arthritis patients. Rheumatol Int 1998;17:197-202.
15. Pavelka K, Forejtova S, Pavelkova A, Zrarova J, Rovensky J, Tuchynova A. Analysis of the reasons for DMARD therapy discontinuation in patient with rheumatoid arthritis in the Czech and Slovak Republics. Clin Rheumatol 2002; 21: 220-6.